We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+4.47%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$563M
AUM Growth
+$59.4M
Cap. Flow
+$52M
Cap. Flow %
9.23%
Top 10 Hldgs %
30.6%
Holding
102
New
10
Increased
33
Reduced
31
Closed
5

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$14.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$14.4M
3
BIIB icon
Biogen
BIIB
+$11.1M
4
CELG
Celgene Corp
CELG
+$8.17M
5
ENDP
Endo International plc
ENDP
+$7.77M

Top Sells

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$11.1M
2
STJ
St Jude Medical
STJ
+$9.9M
3
MDVN
MEDIVATION, INC.
MDVN
+$6.07M
4
PRGO icon
Perrigo
PRGO
+$4.25M
5
LH icon
Labcorp
LH
+$3.76M

Sector Composition

Rank Sector Weight
1 Healthcare 93.53%
2 Financials 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HTWR
101
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
– –
-100,000
Closed -$3.14M
BIND
102
DELISTED
BIND THERAPEUTICS INC
BIND
– –
-133,535
Closed -$294K
1 2 3 4
5

Similar funds

PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
GCM
Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return
CL
CVFG LLC Shelbyville, Indiana $804M AUM 27.61% 1-Year Est. Return

Rhenman & Partners Asset Management's Q2 2016 Portfolio in Review

As of Q2 2016, Rhenman & Partners Asset Management held 102 positions worth $563M, up 12% from $504M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Rhenman & Partners Asset Management deployed $52M of net new capital in Q2 2016, opening 10 new positions and adding to 33 existing holdings. Its largest new stake was Pediatrix Medical: 80,000 shares worth $5.79M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 93% a quarter earlier, followed by Financials.

On the sell side, the largest reduction was Alkermes, an estimated $11.1M trimmed.

  • Rhenman & Partners Asset Management's largest Q2 2016 buy was Pediatrix Medical: 80,000 shares worth $5.79M.
  • Rhenman & Partners Asset Management added most to Alexion Pharmaceuticals in Q2 2016, an estimated $14.5M increase.
  • Rhenman & Partners Asset Management's biggest Q2 2016 reduction was Alkermes, cutting an estimated $11.1M.
  • Rhenman & Partners Asset Management fully exited St Jude Medical in Q2 2016, selling an estimated $9.9M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 31% of its $563M portfolio in Q2 2016.
  • Rhenman & Partners Asset Management opened 10 new positions and closed 5 in Q2 2016.
  • Rhenman & Partners Asset Management's portfolio value rose 12% quarter-over-quarter to $563M.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2016, filed 1 Aug 2016.